Verastem Inc.

NASDAQ: VSTM
Share price (3/17/25): $7.23
Market cap (3/17/25): $322 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Issuer tender offer – amended

Ownership Filter

Alyeska Investment Group, L.P.

Nantahala Capital Management, LLC

Balyasny Asset Management L.P.

Biotechnology Value Fund L P

News Filter

Investor Presentation

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Oncology Announces Debt Refinancing With Oberland Capital and Strategic Commercialization Partnership With IQVIA to Support Potential Launch in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer in Mid-2025

Oncology Presents Positive Updated RAMP 201 Data for Avutometinib and Defactinib Combination in Recurrent Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society (IGCS) 2024 Annual Meeting

Part II Information Not Required in Prospectus

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC